Metabolic syndrome is a predictor for an ECG sign of no-reflow after primary PCI in patients with acute ST-elevation myocardial infarction
- 31 July 2008
- journal article
- Published by Elsevier BV in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 18 (6), 441-447
- https://doi.org/10.1016/j.numecd.2007.02.015
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- The "no-reflow" phenomenon: basic science and clinical correlatesHeart, 2002
- Neutrophils are primary source of O2radicals during reperfusion after prolonged myocardial ischemiaAmerican Journal of Physiology-Heart and Circulatory Physiology, 2001
- Shifting the open-artery hypothesis downstream: the quest for optimal reperfusionJournal of the American College of Cardiology, 2000
- Microvascular dysfunction in acute myocardial infarction: focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenonThe American Journal of Cardiology, 2000
- Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarctionThe Lancet, 1997
- Myocardial Perfusion Patterns Related to Thrombolysis in Myocardial Infarction Perfusion Grades After Coronary Angioplasty in Patients With Acute Anterior Wall Myocardial InfarctionCirculation, 1996
- Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusionNature Medicine, 1996
- Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow.Circulation, 1989
- Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first?Circulation, 1980
- The “No-Reflow” Phenomenon after Temporary Coronary Occlusion in the DogJCI Insight, 1974